hCG

01 · What is it?

The identity comes first.

Human chorionic gonadotropin is a large hormone best known for its role in pregnancy. It is a glycoprotein hormone, not a small synthetic peptide of the type usually discussed in research catalogs. Its alpha and beta subunits together create its biological identity.

Scientific classification: Glycoprotein hormone; two protein subunits with attached sugars

For example. Think of a two-piece message with sugar tags, rather than a short strand carrying a few amino acids.

02 · How does it work?

The signal, explained.

It binds the same receiving system used by luteinizing hormone. Cells in ovaries or testes can then change their production of reproductive hormones.

The key research focus is LH/chorionic gonadotropin receptor (LHCGR). A target describes where an interaction may occur; it does not by itself establish a benefit.

03 · What happens after the signal?

Follow the downstream effects.

Receptor activation influences steroidogenesis, including progesterone or testosterone production depending on the tissue. Endocrine feedback and reproductive stage determine the result.

To connect this mechanism to a real-world outcome, researchers need to establish exposure at the target, measure the response and test whether the change matters in a controlled human study.

04 · What is it commonly researched for?

The questions researchers are asking.

Researchers and clinical programs examine fertility and defined endocrine conditions. Weight-loss claims are not supported by its approved role.

These are areas of investigation, not promises about a Maison product.

05 · Body systems involved

Where the biology connects.

Reproductive system

Relevant to gonadal hormone signaling, uterine physiology or fertility research.

06 · Receptor / target profile

The molecular reference card.

Primary receptor or target

LH/chorionic gonadotropin receptor (LHCGR)

Secondary interactions

No additional primary target established for the research claim discussed.

Where it is found

Ovarian theca/luteal cells and testicular Leydig cells.

Activation, inhibition or interaction

LHCGR agonism primarily stimulates Gs/cAMP/PKA signaling in gonadal cells. This overlaps with luteinizing-hormone signaling but differs in kinetics and physiological context.

Important downstream pathways

Receptor activation influences steroidogenesis, including progesterone or testosterone production depending on the tissue. Endocrine feedback and reproductive stage determine the result.

07 · Evidence quality

What carries weight—and what does not.

A familiar mechanism, a patent, a testimonial or a trial registration alone cannot establish human efficacy or product quality.

08 · Who is studying it?

Follow the original research.

No current sponsor-led clinical development program was verified for this exact research identity. This does not prove that no study exists; consult current records and distinguish related molecules.

Regulatory context: Approved medical formulations exist. A research identity or blend does not inherit their authorization.

Registry links may include related compounds or historical studies. Read the exact intervention, sponsor, phase and latest update date. Recruitment status is specific to each trial.

09 · Research terminology

A small glossary for this page.

Explore the complete foundations glossary

10 · Research status & limitations

Keep the boundaries visible.

Approved medical formulations exist. A research identity or blend does not inherit their authorization.

Long-term outcomes, comparative benefit, clinically meaningful effects and safety for broad wellness use are not well established.

The main evidence category here is established or regulatory evidence. The exact molecule, formulation, study population and endpoint matter. Scientific evidence changes; this page is a dated educational summary, not continuous trial monitoring.